Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups.

× No keyword cloud information.

15 in total

1. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.

Authors: S P Lee; W A Thomas; R J Murray; F Khanim; S Kaur; L S Young; M Rowe; M Kurilla; A B Rickinson
Journal: J Virol Date: 1993-12 Impact factor: 5.103

2. HLA association with nasopharyngeal carcinoma in southern Tunisia.

Authors: Hafedh Makni; Jamel Daoud; Hanène Ben Salah; Nedia Mahfoudh; Olfa Haddar; Héla Karray; Tahya Boudawara; Abdelmonême Ghorbel; Abdelmajid Khabir; Mounir Frikha
Journal: Mol Biol Rep Date: 2009-08-28 Impact factor: 2.316

3. [Monoclonal antibodies against surface antigens of laryngeal carcinoma cells (author's transl)].

Authors: H P Zenner
Journal: Arch Otorhinolaryngol Date: 1981

4. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.

Authors: J H Joncas; E Rioux; J P Wastiaux; M Leyritz; L Robillard; J Menezes
Journal: Can Med Assoc J Date: 1976-11-06 Impact factor: 8.262

Review 9. Recent studies with EB virus.

Authors: M A Epstein
Journal: Yale J Biol Med Date: 1975-11

10. Heterogeneity revealed through meta-analysis might link geographical differences with nasopharyngeal carcinoma incidence in Han Chinese populations.

Authors: Wen-Hui Su; Chi-Cking Chiu; Yin Yao Shugart
Journal: BMC Cancer Date: 2015-08-26 Impact factor: 4.430

Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups.

1. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.

2. HLA association with nasopharyngeal carcinoma in southern Tunisia.

3. [Monoclonal antibodies against surface antigens of laryngeal carcinoma cells (author's transl)].

4. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.

Review 5. Immune regulation in Epstein-Barr virus-associated diseases.

Review 6. The roles of ribosomal proteins in nasopharyngeal cancer: culprits, sentinels or both.

7. M2 alpha-1-antitrypsin phenotype and primary liver cancer.

Review 8. Commentary. EB virus, infectious mononucleosis, and cancer: the closing of the web.

Review 9. Recent studies with EB virus.

10. Heterogeneity revealed through meta-analysis might link geographical differences with nasopharyngeal carcinoma incidence in Han Chinese populations.